Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Epocrates Inc. (EPOC)

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. (“Epocrates” or the “Company”) (NASDAQ: EPOC) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to athenahealth Inc. (NASDAQ: ATHN) in an all-cash deal valued at approximately $293 million. Under the terms of the proposed transaction, Epocrates’ stockholders will receive $11.75 in cash for each share of Epocrates common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $15 for Epocrates.